Healthcare Reimbursement Services for Infectious Disease Practices

The available services address major reimbursement and revenue-cycle needs for infectious disease practices. They include claims management, denial management and appeals, payment reconciliation, eligibility and authorization support, credentialing and payer enrollment, A/R recovery, contract compliance, workflow improvement, and revenue leakage identification. Coverage can include E/M, infusion, drug, hospital consult, OPAT, and specialty-drug activities when relevant to the practice.

Revenue leakage can occur through under-leveled visits, missed drug or administration charges, documentation gaps, incorrect coding, contract issues, and unpursued balances. Revenue-cycle analysis traces the problem to its source across documentation, charge capture, payer rules, payment posting, and collections. Reporting by payer, service line, and provider can make denial patterns, payment trends, and A/R health easier to evaluate.

Denial management begins by organizing denials according to their underlying cause, such as drug and administration coding, missing authorization, medical-versus-pharmacy benefit confusion, or incomplete consult documentation. Payer-specific appeals can then be supported with relevant clinical records. Findings should also return to clinical, coding, and front-office teams so recurring issues are addressed rather than repeatedly appealed.

Payment reconciliation compares payer payments with expected reimbursement for drug, administration, and E/M claims. The review can identify short-pays, incorrect fee schedule application, and unit or NDC mismatches. When an issue is found, it can be disputed, documented, and tracked through recovery. This is particularly relevant when a practice buys and bills drugs, because underpayment affects the practice balance sheet directly.

Eligibility and authorization work helps determine whether a therapy is covered, which benefit applies, and what requirements must be satisfied before treatment. For infectious disease practices, this may involve infusions, OPAT courses, or specialty drugs. Tracking each request supports better coordination between the practice, payer, and patient while reducing the risk that the practice is left holding an unreimbursed drug cost.

Yes. Infectious disease practices may have separate revenue streams for office visits, hospital consults, infusion, and contracted services, and each may require appropriate enrollment before billing. Support can include CAQH, commercial and government payer enrollment, and re-credentialing for physicians and APPs. Enrollment can also address infusion and OPAT services so each applicable site and service is prepared for billing.

Revenue-cycle improvement reviews the workflow from referral through final payment. Areas may include documentation and coding, eligibility and prior authorization, drug and infusion billing, denials, underpayments, A/R follow-up, and payer or hospital coverage contracts. The goal is to locate where revenue is lost, delayed, or left uncollected, trace each gap to its cause, and organize practical priorities for improvement.

The resources are designed for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. They are relevant to practices evaluating revenue streams, launching or managing infusion and OPAT services, reviewing operational decisions, or assessing financial sustainability. Users can apply their own practice numbers rather than relying on generalized rates, margins, or assumptions.